Work

Post-hoc Analysis of Descartes-08, BCMA-directed mRNA CAR-T Therapy, in Biologic Non-responsive Versus Biologic Naive Generalized Myasthenia Gravis: Results from a Phase 2b Randomized Trial (P9-9.020)

Year: 2026

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000217343

Authors: Milos Miljkovic, Tuan Vu, Hacer Durmus, Christopher Jewell, Hafsa Kamboh, Eva Rybak, Renee Fedak, Tahseen Mozaffar, James Howard

Institutions: Cartesian Therapeutics, Inc. (United States), University of South Florida, Istanbul University, University of California, Irvine, University of North Carolina at Chapel Hill

Language: English

Topic: Myasthenia Gravis and Thymoma

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7164201828

FWCI:

Cites:

Cited by:

Related to: 10